Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    Change Detected
    Summary
    Eli Lilly has announced the date for its second-quarter 2024 financial results and a conference call on August 8, 2024, while the previous announcement regarding Melissa Seymour joining as executive vice president of Global Quality has been removed.
    Difference
    14%
    Check dated 2024-07-25T16:03:22.000Z thumbnail image
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    Lilly has announced the acquisition of Morphic to enhance outcomes for patients with Inflammatory Bowel Disease by expanding their immunology pipeline with oral integrin therapies.
    Difference
    15%
    Check dated 2024-07-08T23:06:46.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage value has changed to 'Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease on July 2, 2024'. This represents a significant update regarding the approval of a new treatment for Alzheimer's disease by Eli Lilly and Company.
    Difference
    15%
    Check dated 2024-07-03T15:55:46.000Z thumbnail image
  8. Check
    31 days ago
    Change Detected
    Summary
    The webpage content has been updated to reflect that Lilly has shifted its focus from participating in the Goldman Sachs 45th Annual Global Healthcare Conference to collaborating with OpenAI to discover novel medicines for treating drug-resistant bacteria.
    Difference
    14%
    Check dated 2024-06-26T10:24:23.000Z thumbnail image
  9. Check
    32 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site' to 'Lilly Declares Third-Quarter 2024 Dividend of $1.30 per share.' This represents a shift from investment in manufacturing to dividend declaration.
    Difference
    15%
    Check dated 2024-06-25T09:30:31.000Z thumbnail image
  10. Check
    35 days ago
    Change Detected
    Summary
    The value of Lilly's tirzepatide reducing obstructive sleep apnea (OSA) severity has been updated, with up to 51.5% of participants now meeting the criteria for disease resolution.
    Difference
    15%
    Check dated 2024-06-22T05:38:18.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.